Our state-of-the-art genomics facility is taking a giant leap forward with the NovaSeq X, powering our rare disease research program and paving the way for a new CLIA-certified lab. This will enable us to translate groundbreaking research into real-world treatments and, ultimately, find cures for challenging rare disorders.